Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Nov 27, 2023

SELL
$76.01 - $86.7 $1.05 Million - $1.2 Million
-13,836 Reduced 33.65%
27,283 $2.1 Million
Q1 2023

Nov 27, 2023

BUY
$77.31 - $88.08 $3.18 Million - $3.62 Million
41,105 Added 293607.12%
41,119 $3.41 Million
Q3 2022

Oct 24, 2022

SELL
$59.54 - $68.01 $1,488 - $1,700
-25 Reduced 64.1%
14 $1,000
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $1,443 - $1,625
25 Added 178.57%
39 $2,000
Q1 2022

Aug 16, 2022

SELL
$57.92 - $72.58 $1.37 Million - $1.71 Million
-23,583 Reduced 99.94%
14 $1,000
Q4 2021

Feb 10, 2022

BUY
$64.88 - $73.64 $437,550 - $496,628
6,744 Added 40.02%
23,597 $1.71 Million
Q3 2021

Nov 08, 2021

BUY
$67.69 - $73.03 $1.14 Million - $1.23 Million
16,853 New
16,853 $1.18 Million
Q4 2020

Jan 29, 2021

SELL
$56.65 - $64.55 $0 - $0
0 Closed
0 $0
Q3 2020

Oct 09, 2020

BUY
$62.1 - $78.08 $0 - $0
0 New
0 $0
Q2 2020

Aug 11, 2020

SELL
$72.34 - $84.0 $3.23 Million - $3.76 Million
-44,705 Closed
0 $0
Q1 2020

Apr 13, 2020

BUY
$62.63 - $80.22 $2.8 Million - $3.59 Million
44,705 New
44,705 $3.34 Million
Q1 2019

May 14, 2019

SELL
$62.53 - $70.05 $450,090 - $504,219
-7,198 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $435,766 - $568,642
7,198 New
7,198 $556,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.